AXIM BIOTECHNOLOGIES, INC. (AXIM)
AXIM Biotechnologies, Inc. specializes in the creation and distribution of advanced diagnostic solutions for healthcare, focusing on critical areas such as SARS-CoV-2 (COVID-19), ocular health, and cancer treatment. The company is currently developing rapid diagnostic assays that quantify functional neutralizing antibodies, which are essential for preventing the SARS-CoV-2 virus from attaching to human cells. Additionally, it offers serological diagnostic tests designed to detect neutralizing antibodies, thereby assessing the body's adaptive immune response to the virus, and is developing tests to identify inflammation biomarkers for the effective management of COVID-19 patients. For eye health, AXIM is pioneering quick, quantitative tear tests to measure Matrix metalloproteinase-9, an inflammatory marker associated with dry eye disease. In its oncology pipeline, the firm is advancing SBI-183, an anti-metastatic compound engineered to inhibit tumor cell growth and block the spread of cancer, as well as SPX-1009, another anti-metastatic therapy aimed at determining the levels of quiescin sulfhydryl oxidase I. Established in 2010, the company was formerly known as Axim International Inc. before officially changing its name to AXIM Biotechnologies, Inc. in July 2014, and it is headquartered in San Diego, California.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
AXIM Biotechnologies, Inc.
No splits on record
Nothing in AXIM's public trading history: no forward or reverse split has affected the share count.
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
| Revenue | $0 | $70K | $40K | $9K | $60K | $0 | $799K | $196K | $48K | $47K | $49K | $0 | $22K | $43K | $10K |
| YoY Growth | - | 78.3% | 345.3% | -85.3% | - | - | 308.7% | 311.2% | 1.1% | -4.2% | - | - | -50.0% | 333.3% | - |
| Cost of Revenue | $427K | $440K | $427K | $426K | $2.12M | $16K | $576K | $9K | $43K | $154K | $50K | $0 | $0 | $0 | $0 |
| Gross Profit | -$427K | -$369K | $40K | -$417K | $60K | -$16K | $224K | $187K | $5K | -$107K | -$1K | $0 | $22K | $43K | $10K |
| Gross Margin | - | -524.1% | 100.0% | -4701.4% | 100.0% | - | 28.0% | 95.6% | 9.9% | -227.5% | -2.5% | - | 100.0% | 100.0% | 100.0% |
| Research and Development | $180K | $40K | $125K | $154K | $285K | $427K | $2.45M | $2.06M | $1.35M | $236K | $571K | $0 | $0 | $0 | $0 |
| Selling, General, and Administrative | $712K | $1.35M | $2.24M | $4.08M | $5.67M | $4.51M | $4.27M | $3.16M | $1.8M | $3.41M | $9.48M | $506K | $33K | $41K | $0 |
| Other | $0 | $432K | $427K | $426K | $1.84M | -$100K | $3K | $3K | $3K | $3K | $1K | $0 | $111K | $58K | $13K |
| Total Operating Expenses | $892K | $1.39M | $2.79M | $4.66M | $7.79M | $4.83M | $6.73M | $5.22M | $3.15M | $3.65M | $10.05M | $506K | $111K | $58K | $13K |
| Operating Income (EBIT) | -$1.32M | -$1.76M | -$2.75M | -$4.65M | -$7.99M | -$4.95M | -$6.51M | -$5.04M | -$3.15M | -$3.76M | -$10.05M | -$506K | -$89K | -$15K | -$3K |
| Operating Margin | - | -2502.3% | -6961.0% | -52425.6% | -13207.1% | - | -813.7% | -2574.5% | -6619.5% | -7988.8% | -20451.3% | - | -411.8% | -34.4% | -27.9% |
| Interest Expense | $342K | $636K | $1.2M | $1.88M | $743K | $321K | $324K | $1.58M | $1.02M | $301K | $43K | $33K | $0 | $0 | $0 |
| Interest Income | $0 | $0 | $0 | $257 | $1K | $675 | $298K | $0 | $2K | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | $277K | -$1.75M | -$5.31M | -$1.59M | -$2.05M | -$1.34M | $58K | -$1.72M | -$1.02M | -$2.05M | -$43K | -$33K | $0 | $0 | $0 |
| Income Before Tax (EBT) | -$1.04M | -$3.51M | -$8.06M | -$6.24M | -$16.02M | -$6.29M | -$6.45M | -$6.75M | -$4.17M | -$5.81M | -$10.09M | -$538K | -$89K | -$15K | -$3K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $324K | $0 | $0 | $0 | $0 | $0 | -$30K | $0 | $0 |
| Net Income | -$1.04M | -$3.51M | -$8.06M | -$5.96M | -$16.52M | -$6.73M | -$6.77M | -$6.75M | -$4.17M | -$5.81M | -$10.09M | -$583K | -$89K | -$15K | -$3K |
| Net Income Margin | - | -4985.2% | -20395.0% | -67120.7% | -27320.8% | - | -847.0% | -3453.0% | -8761.7% | -12346.0% | -20539.2% | - | -411.8% | -34.4% | -27.9% |
| Supplementary Data | |||||||||||||||
| EPS | -0.00 | -0.01 | -0.04 | -0.04 | -0.13 | -0.06 | -0.11 | -0.12 | -0.08 | -0.14 | -0.27 | -0.02 | -0.00 | -0.00 | -0.00 |
| Diluted EPS | -0.00 | -0.01 | -0.04 | -0.04 | -0.13 | -0.06 | -0.11 | -0.12 | -0.08 | -0.14 | -0.27 | -0.02 | -0.00 | -0.00 | -0.00 |
| Weighted Average OS | 340.46M | 318.90M | 227.69M | 165.47M | 131.54M | 110.39M | 61.95M | 57.28M | 53.30M | 41.73M | 37.05M | 33.00M | 33.00M | 33.00M | 23.28M |
| EBITDA | -$892K | -$2.44M | -$6.43M | -$3.94M | -$13.17M | -$4.93M | -$2.67M | -$5.16M | -$3.14M | -$5.51M | -$10.05M | -$504K | -$79K | -$9K | -$2K |
| EBITDA Margin | - | -3468.6% | -16265.7% | -44398.9% | -21775.3% | - | -333.5% | -2639.3% | -6609.1% | -11698.3% | -20449.0% | - | -365.6% | -21.8% | -19.6% |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
| Assets | |||||||||||||||
| Current Assets | |||||||||||||||
| Cash and Cash Equivalents | $5K | $245 | $156K | $47K | $453K | $457K | $512K | $1.81M | $2.06M | $713K | $134K | $661K | $127 | $19K | $23K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $241K | $150K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $5K | $245 | $156K | $47K | $453K | $457K | $753K | $1.96M | $2.06M | $713K | $134K | $661K | $127 | $19K | $23K |
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $321K | $5K | $5K | $505K | $5K | $5K | $3K | $20K | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $488K | $10K | $9K | $38K | $201K | $0 | -$3K | $0 | $0 |
| Other Current Assets | $0 | $0 | $0 | $14K | $20K | $0 | $27K | $0 | $0 | $76K | $0 | $0 | $3K | $0 | $0 |
| Total Current Assets | $5K | $755 | $156K | $104K | $637K | $713K | $1.64M | $2.02M | $2.11M | $1.37M | $1.18M | $738K | $3K | $39K | $23K |
| Long-Term Assets | |||||||||||||||
| Property, Plant & Equipment Net | $66K | $237K | $361K | $114K | $194K | $235K | $2K | $6K | $9K | $12K | $16K | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $2.46M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $2.81M | $3.2M | $3.59M | $3.99M | $4.38M | $7.8M | $51K | $54K | $63K | $63K | $63K | $0 | $54K | $94K | $49K |
| Long-Term Investments | $0 | $0 | $0 | $46K | $104K | $103K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | -$46K | -$104K | -$103K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $9K | $9K | $5K | $109K | $108K | $0 | $7K | $7K | $0 | $0 | $0 | $0 | -$94K | $0 |
| Total Long-Term Assets | $2.87M | $3.45M | $3.97M | $4.11M | $4.69M | $10.6M | $53K | $67K | $80K | $75K | $79K | $0 | $54K | $94K | $49K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $2.88M | $3.45M | $4.12M | $4.21M | $5.32M | $11.31M | $1.69M | $2.09M | $2.19M | $1.45M | $1.26M | $738K | $57K | $133K | $72K |
| Liabilities | |||||||||||||||
| Current Liabilities | |||||||||||||||
| Accounts Payable | $1.74M | $1.79M | $2.78M | $1.32M | $816K | $738K | $750K | $218K | $442K | $401K | $324K | $144K | $53K | $33K | $6K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $1.61M | $369K | $42K | $2.69M | $7.26M | $2.61M | $1.11M | $1.11M | $50K | $50K | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $233K | $303K | $333K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $22K | $0 |
| Other Current Liabilities | $4.34M | $4.67M | $2.8M | $1.72M | $180 | $180 | $2.6M | $413K | $0 | $5K | $1.11M | $94K | $48K | $33K | $51K |
| Total Current Liabilities | $6.08M | $6.76M | $5.98M | $3.39M | $2.58M | $1.5M | $3.4M | $3.32M | $7.71M | $3.02M | $2.56M | $1.32M | $151K | $138K | $56K |
| Long-Term Liabilities | |||||||||||||||
| Long-Term Debt | $7.78M | $6.5M | $5.66M | $5.64M | $5.06M | $5.84M | $5.06M | $4.85M | $772K | $804K | $400K | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | -$2.34M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $2.34M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $381K | $541K | $0 | $0 | $0 | $2.34M | $0 | $0 | $0 | $0 | $11K | $0 | $0 | $0 | $6K |
| Total Long-Term Liabilities | $8.17M | $7.1M | $5.8M | $5.64M | $5.08M | $8.25M | $5.06M | $4.85M | $772K | $804K | $400K | $1.19M | $103K | $104K | $6K |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$1.19M | -$103K | -$104K | $0 |
| Total Liabilities | $14.24M | $13.87M | $11.78M | $9.04M | $7.66M | $9.75M | $8.45M | $8.17M | $8.48M | $3.82M | $2.96M | $1.32M | $151K | $138K | $62K |
| Stockholders' Equity | |||||||||||||||
| Preferred Stock | $50 | $50 | $50 | $50 | $50 | $50 | $100 | $100 | $100 | $100 | $200 | $100 | $100 | $100 | $100 |
| Common Stock | $34K | $32K | $25K | $19K | $14K | $13K | $6K | $6K | $5K | $5K | $4K | $3K | $3K | $3K | $3K |
| Retained Earnings | -$76.74M | -$75.7M | -$72.18M | -$64.13M | -$57.88M | -$41.85M | -$35.44M | -$28.99M | -$22.24M | -$18.07M | -$10.78M | -$692K | -$109K | -$20K | -$5K |
| Comprehensive Income & Other | $0 | $0 | -$24K | $89K | $4.53M | $202K | $50K | -$100 | -$100 | -$100 | -$200 | -$100 | -$100 | -$100 | -$100 |
| Other Stockholders' Equity | $65.34M | $65.25M | $64.5M | $59.28M | $55.53M | $43.4M | $28.67M | $22.9M | $15.95M | $15.69M | $9.09M | $108K | $12K | $12K | $12K |
| Total Equity | -$11.37M | -$10.42M | -$7.66M | -$4.83M | -$2.34M | $1.57M | -$6.76M | -$6.08M | -$6.28M | -$2.37M | -$1.7M | -$581K | -$94K | -$5K | $10K |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $2.88M | $3.45M | $4.12M | $4.21M | $5.32M | $11.31M | $1.69M | $2.09M | $2.19M | $1.45M | $1.26M | $738K | $57K | $133K | $72K |
| Supplementary Data | |||||||||||||||
| Total Debt | $7.78M | $6.64M | $5.89M | $5.66M | $6.72M | $6.31M | $6.1M | $5.87M | $6.4M | $1.77M | $1.45M | $1.05M | $50K | $50K | $0 |
| Net Debt | $7.78M | $6.64M | $5.74M | $5.62M | $6.27M | $5.85M | $5.59M | $4.06M | $4.34M | $1.06M | $1.32M | $389K | $50K | $31K | -$23K |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
| Operating Activities | |||||||||||||||
| Net Income | -$1.04M | -$3.51M | -$8.06M | -$6.24M | -$16.03M | -$6.41M | -$6.45M | -$6.75M | -$4.17M | -$5.81M | -$10.09M | -$583K | -$89K | -$15K | -$3K |
| Depreciation & Amortization | $427K | $432K | $427K | $426K | $2.12M | $16K | $3K | $13K | $3K | $3K | $1K | $2K | $10K | $5K | $832 |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $7.55M | -$78K | -$382K | $140K | $0 | $1.61M | $673K | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $0 | $0 | $198K | $1.11M | $1.14M | $2.31M | $1.83M | $911K | $56K | $1.45M | $5.98M | $0 | $0 | $0 | $0 |
| Changes in Working Capital: | |||||||||||||||
| Accounts Receivable | $0 | $0 | $0 | $2K | -$1K | -$675 | -$316K | $0 | $174K | $0 | $0 | -$4K | $9K | $45K | $0 |
| Inventory | $0 | $0 | $0 | $20K | -$20K | $675 | -$478K | -$1K | $30K | $153K | $46K | $0 | $0 | $0 | $0 |
| Accounts Payable | -$361K | $638K | $769K | $659K | $277.51B | $532K | $674K | -$116K | $41K | $189K | $249K | $146K | $20K | $27K | $6K |
| Other Working Capital | -$52K | $145K | $523K | $358K | -$277.51B | -$46K | -$111K | -$101K | -$7K | -$52K | -$181K | -$22K | -$12K | $3K | $500 |
| Total Working Capital Change | -$412K | $783K | $1.29M | $1.04M | -$28K | $486K | -$231K | -$218K | $237K | $290K | $114K | $123K | $8K | $31K | $6K |
| Other Non-Cash Items | $342K | $1.44M | $5.11M | $1.63M | $2.77M | $459K | $203K | $1.06M | $790K | $1.17M | $1.79M | $118K | $38K | $31K | $0 |
| Net Cash from Operating | -$686K | -$855K | -$1.03M | -$2.04M | -$2.49M | -$3.22M | -$5.02M | -$4.85M | -$3.08M | -$1.29M | -$1.54M | -$339K | -$33K | $21K | $4K |
| Investing Activities | |||||||||||||||
| Capital Expenditures | $0 | -$3K | $0 | -$9K | -$50K | -$97K | $0 | $0 | $0 | $0 | -$17K | $0 | $0 | -$100K | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $80K | -$27K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $376K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | -$9K | -$10K | $27K | -$27K | $0 | $0 | $0 | -$17K | $0 | $0 | -$100K | $0 |
| Net Cash from Investing | $0 | -$3K | $0 | -$9K | -$50K | $10K | $348K | $0 | $0 | $0 | -$17K | $0 | $0 | -$100K | $0 |
| Financing Activities | |||||||||||||||
| Debt Repaid | -$650K | -$480K | -$675K | $8K | -$1.01M | $93K | -$11K | $184K | -$3.94M | -$1.23M | - | - | - | -$50K | - |
| Common Stock Issuance | $8K | $222K | $491K | $1.74M | $1.64M | $3.31M | $3.46M | $4.37M | $115K | $115K | $20K | $0 | $0 | $0 | $13K |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $5.3M | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$1.48M | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | -$27K | -$87K | $1.64M | -$65K | -$79K | $408K | $1.98M | $533K | $1.01M | -$5K | $0 | $25K | $0 |
| Net Cash from Financing | $658K | $702K | $1.14M | $1.65M | $2.53M | $3.15M | $3.38M | $4.59M | $4.43M | $1.87M | $1.03M | $1M | $14K | $75K | $19K |
| Forex Effect | $33K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $5K | -$156K | $109K | -$406K | -$4K | -$54K | -$1.29M | -$252K | $1.34M | $579K | -$527K | $661K | -$19K | -$4K | $23K |
| Supplementary Data | |||||||||||||||
| Operating Cash Flow | -$686K | -$855K | -$1.03M | -$2.04M | -$2.49M | -$3.22M | -$5.02M | -$4.85M | -$3.08M | -$1.29M | -$1.54M | -$339K | -$33K | $21K | $4K |
| Capital Expenditure | $0 | -$3K | $0 | -$9K | -$50K | -$97K | $0 | $0 | $0 | $0 | -$17K | $0 | $0 | -$100K | $0 |
| Free Cash Flow | -$686K | -$858K | -$1.03M | -$2.05M | -$2.54M | -$3.31M | -$5.02M | -$4.85M | -$3.08M | -$1.29M | -$1.56M | -$339K | -$33K | -$79K | $4K |
| Cash at Beginning | $245 | $156K | $47K | $453K | $457K | $512K | $1.81M | $2.06M | $713K | $134K | $661K | $127 | $19K | $23K | $0 |
| Cash at End | $5K | $245 | $156K | $47K | $453K | $457K | $512K | $1.81M | $2.06M | $713K | $134K | $661K | $127 | $19K | $23K |